Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T21334 | ||||
Target Name | Osteoclast differentiation factor | ||||
Synonyms | ODF; OPGL; Osteoclast differentiation factor; Osteoprotegerin ligand; RANKL; Receptor activatorof nuclear factor kappa B ligand; TNF-related activation-induced cytokine; TRANCE; TNFSF11 | ||||
Target Type | Successful | ||||
Gene Name | TNFSF11 | ||||
Biochemical Class | Cytokine: tumor necrosis factor | ||||
UniProt ID | TNF11_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Osteoporosis | ||||
Example drug | Denosumab | Approved | [531351], [541943], [1572592] | ||
Tissue | Bone marrow | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -0.16 Z-score: -0.37 P-value: 6.42E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Disease | Rheumatoid arthritis | ||||
Example drug | Denosumab | Phase 2 | [531351], [541943], [1572592] | ||
Tissue | Synovial tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 0.53 Z-score: 1.49 P-value: 1.51E-02 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.